IVUS-Guided PCI Was More Cost Effective than Angio-Guided PCI in Studies
Adverse cardiac events are a substantial burden to the health system:
1. Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014; 113(8), 1,338-47.
2. Wizenbichler B, Maehara A, Weisz G, Neumann FJ, et al.: Relationship between Intravascular Ultrasound Guidance and Clinical Outcomes after Drug-Eluting Stents: The Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) Study. Circulation. 2014; 129, 463-470.
3. Wasserman M, Priest V, Simmonds M. The long and the short of it: A comparison of ICERs for intravascular ultrasound (IVUS) using short and long-term benefit assumptions. Health Technology Assessment International Conference. 15-19 June 2013; Seoul, South Korea.
* Assumes a weighted average cost of $8,039 per MI (50% treated medically, $1,730 and 50% treated with revascularization; weighted average cost of $14,348 per revascularization (90% treated with PCI, $11,541 and 10% with CABG, $39,617); MI drug costs used calculated AWP (WAC + 20%)
† Assumes a weighted average cost of $12,948 per revascularization (90% treated with PCI, $11,541 and 10% treated with CABG, $25,612)